null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1080223409

Enrollment

Registered

2016-12-08

Start date

2016-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial Esophageal Cancer After Endoscopic Submucosal Dissection (ESD)

Interventions

investigational material(s) Generic name etc : INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material :

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
efficacy	—

Secondary

Measure	Time frame
safety efficacy 1.Time to wound healing 2.Number of esophageal balloon dilatations 3.Number of participants reporting one or more adverse events and product deficiencies 4.Quality of Life (QOL) measured with the EORTC QLQ-C30 5.QOL assessed by the EORTC QLQ-OG 25	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026